cetylpyridinium chloride anhydrous and Carcinoma, Non-Small Cell Lung

cetylpyridinium chloride anhydrous has been researched along with Carcinoma, Non-Small Cell Lung in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Izbicki, JR; Pantel, K; Roth, C; Schwarzenbach, H; Stückrath, I; Tachezy, M	1
Byrne, LM; Csiki, I; Johnson, DH; Morrow, JD; Murphey, LJ; Oates, JA; Sanchez, SC; Williams, MK	1

Other Studies

2 other study(ies) available for cetylpyridinium chloride anhydrous and Carcinoma, Non-Small Cell Lung

Article	Year
Low levels of cell-free circulating miR-361-3p and miR-625* as blood-based markers for discriminating malignant from benign lung tumors. PloS one, 2012, Volume: 7, Issue:6 Topics: Adult; Aged; Aged, 80 and over; Biomarkers, Tumor; Carcinoma, Non-Small-Cell Lung; Cell-Free System; Cohort Studies; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Health; Humans; Lung Neoplasms; MicroRNAs; Middle Aged; Oligonucleotide Array Sequence Analysis; Postoperative Care; Preoperative Care; Reproducibility of Results; Reverse Transcriptase Polymerase Chain Reaction; Smad2 Protein; Smoking; Transforming Growth Factor beta1	2012
Quantification of the major urinary metabolite of PGE2 by a liquid chromatographic/mass spectrometric assay: determination of cyclooxygenase-specific PGE2 synthesis in healthy humans and those with lung cancer. Analytical biochemistry, 2004, Nov-15, Volume: 334, Issue:2 Topics: Carcinoma, Non-Small-Cell Lung; Case-Control Studies; Chromatography, Liquid; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Dinoprostone; Health; Humans; Lung Neoplasms; Membrane Proteins; Molecular Structure; Prostaglandin-Endoperoxide Synthases; Prostaglandins; Reproducibility of Results; Spectrometry, Mass, Electrospray Ionization	2004

Article

Year

Low levels of cell-free circulating miR-361-3p and miR-625* as blood-based markers for discriminating malignant from benign lung tumors.

PloS one, 2012, Volume: 7, Issue:6

Topics: Adult; Aged; Aged, 80 and over; Biomarkers, Tumor; Carcinoma, Non-Small-Cell Lung; Cell-Free System; Cohort Studies; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Health; Humans; Lung Neoplasms; MicroRNAs; Middle Aged; Oligonucleotide Array Sequence Analysis; Postoperative Care; Preoperative Care; Reproducibility of Results; Reverse Transcriptase Polymerase Chain Reaction; Smad2 Protein; Smoking; Transforming Growth Factor beta1

2012

Quantification of the major urinary metabolite of PGE2 by a liquid chromatographic/mass spectrometric assay: determination of cyclooxygenase-specific PGE2 synthesis in healthy humans and those with lung cancer.

Analytical biochemistry, 2004, Nov-15, Volume: 334, Issue:2

Topics: Carcinoma, Non-Small-Cell Lung; Case-Control Studies; Chromatography, Liquid; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Dinoprostone; Health; Humans; Lung Neoplasms; Membrane Proteins; Molecular Structure; Prostaglandin-Endoperoxide Synthases; Prostaglandins; Reproducibility of Results; Spectrometry, Mass, Electrospray Ionization

2004